A detailed history of Raymond James Financial Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 112,980 shares of TMDX stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112,980
Previous 191,349 40.96%
Holding current value
$13 Million
Previous $25.6 Million 50.57%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$103.61 - $132.04 $8.12 Million - $10.3 Million
-78,369 Reduced 40.96%
112,980 $12.7 Million
Q2 2025

Aug 14, 2025

BUY
$67.67 - $143.04 $3.11 Million - $6.57 Million
45,956 Added 31.61%
191,349 $25.6 Million
Q1 2025

May 13, 2025

BUY
$56.73 - $79.42 $4.75 Million - $6.65 Million
83,722 Added 135.76%
145,393 $9.78 Million
Q4 2024

Feb 06, 2025

BUY
$59.28 - $144.9 $3.66 Million - $8.94 Million
61,671 New
61,671 $3.85 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $3.66B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.